Mitotropic compounds for the treatment of age-related macular degeneration: The metabolic approach and a pilot study

Ophthalmologica

Volumn 217, Issue 5, 2003, Pages 351-357

  Feher, J ^a,b   Papale, A ^a   Mannino, G ^a   Gualdi, L ^a   Balacco Gabrieli, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Acetyl L carnitine; Age related macular degeneration; Coenzyme Q 10; Mitochondria; Photoreceptor; Polyunsaturated fatty acids; Retina; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVACECARNINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; UBIDECARENONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; MALE; MITOCHONDRION; OPHTHALMOLOGY; PHOTORECEPTOR; PHOTOSTIMULATION; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT OUTCOME; VISION; VISUAL FIELD;

ACETYLCARNITINE; AGED; ANTIOXIDANTS; DRUG THERAPY, COMBINATION; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIPIDS; MACULAR DEGENERATION; MALE; MIDDLE AGED; MITOCHONDRIA; PEROXISOMES; PILOT PROJECTS; RETINA; UBIQUINONE; VISUAL FIELDS; VITAMIN E;

EID: 0043163463     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071351     Document Type: Article

References (59)

1. Klaver ED, Wolfs RC, Vingerling JR, Hoffman A, de Jong PT: Age-specific prevalence and causes of blindness and visual impairment in an older population: The Rotterdam Study. Arch Ophthalmol 1998;116:653-658.
2. Smith W, Assink J, Klein R, Mitshell P, Klaver CCW, Klein BEK, Hofman A, Jensen S, Wang JJ, de Jong PTVM: Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001;108:697-704.
3. Beatty S, Koh H, Phil M, Henson D, Boulton M: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115-134.
4. Winkler BS, Boulton ME, Gottsch JD, Sternberg P: Oxidative damage and age-related macular degeneration. Mol Vis 1999;3:5-32.
5. Wiegand RD, Giusto NM, Rapp LM, Anderson RE: Evidence for rod outer segment lipid peroxidation following constant illumination of the rat retina. Invest Ophthalmol Vis Sci 1983;24:1433-1435.
6. Sprecher H, Chen Q: Polyunsaturated fatty acid biosynthesis: A microsomal-peroxisomal process. Prostaglandins Leukot Essent Fatty Acids 1999;60:317-321.
7. Ferdinandusse S, Denis S, Mooijer PA, Zhang Z, Reddy JK, Spector AA, Wanders RJ: Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J Lipid Res 2001;42:1987-1995.
8. Feher J, Papale A, Tomei M, Balacco Gabrieli C: Mitochondrial damage and protection in retinal dystrophies (abstract 2637). ARVO Abstracts. Invest Ophthalmol Vis Sci 1998;39:S570.
9. Feher J, Papale A, Balacco Gabrieli C: Peroxisomal contribution to the basement membrane thickening in age-related macular degeneration (abstract 1194). ARVO Abstracts. Invest Ophthalmol Vis Sci 2001;42:S222.
10. Kennedy CJ, Rakoczy PE, Constable IJ: Lipofuscin of the retinal pigment epithelium: A review. Eye 1995;9:262-274.
11. Bird AC: Pathophysiology of AMD; in Hampton CR, Nelson PT (eds): Age-Related Macular Degeneration: Principles and Practice. New York, Raven Press, 1992, pp 63-83.
12. Haimovici R, Gantz DL, Rumelt S, Freddo TF, Small DM: The lipid composition of drusen, Bruch's membrane, and sclera by hot stage polarizing light microscopy. Invest Ophthalmol Vis Sci 2001;42:1592-1599.
13. Spaide RF, Ho-Spaide WC, Browne RW, Armstrong D: Characterization of peroxidized lipids in Bruch's membrane. Retina 1999;19:141-147.
14. Kerner J, Hoppel C: Fatty acid import into mitochondria. Biochim Biophys Acta 2000;1486:1-17.
15. Ando S, Tadenuma T, Tanaka Y, Fukui F, Kobayashi S, Ohashi Y, Kawabata T: Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J Neurosci Res 2001;66:266-271.
16. Uauy R, Mena P, Rojas C: Essential fatty acids in early life: Structural and functional role. Proc Nutr Soc 2000;59:3-15.
17. Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE: Essential fatty acids in visual and brain development. Lipids 2001;36:885-895.
18. + channels by directly binding to the channel proteins. Proc Natl Acad Sci USA 1996;93:3542-3546.
19. Suh M, Wierzbicki AA, Lien EL, Clandinin MT: Dietary 20:4n-6 and 22:6n-3 modulates the profile of long- and very-long-chain fatty acids, rhodopsin content, and kinetics in developing photoreceptor cells. Pediatr Res 2000;48:524-530.
20. Youdim KA, Martin A, Joseph JA: Essential fatty acids and the brain: Possible health implications. Int J Dev Neurosci 2000;18:383-399.
21. Vatassery GT: Determination of tocopherols and tocopherolquinonone in human red blood cells and platelet samples. Methods Enzymol 1994;234:327-331.
22. 10 in Biology and Medicine. Roma, Casa Editrice Scientifica Internazionale, 1994, pp 1-91.
23. 10 and vitamin E alter the status of these compounds in rat tissues and mitochondria. J Nutr 2000;130:2343-2348.
24. Siegel D, Bolton EM, Burr JA, Liebler DC, Ross D: The reduction of alpha-tocopherolquinone by human NAD(P)H:quinone oxidoreductase: The role of alpha-tocopherolhydroquinone as a cellular antioxidant. Mol Pharmacol 1997;52:300-305.
25. 10. Free Radic Biol Med 1999;26:1375-1382.
26. Neuzil J, Witting PX, Stocker R: Alpha-tocopherylhydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low-density lipoprotein lipids. Proc Natl Acad Sci USA 1997;94:7885-7890.
27. 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998;95:8892-8897.
28. Mataix J, Manas M, Quiles J, Battino M, Cassinello M, Lopez-Frias M, Huertas JR: Coenzyme Q content depends upon oxidative stress and dietary fat unsaturation. Mol Aspects Med 1997;18(suppl):129-135.
29. 10 in redox signaling and inhibition of death signaling in the rat heart mitochondria. Antioxid Redox Signal 2001;3:103-112.
30. Wu G, Weiter M, Santos S, Ginsburg L, Villalobos R: The macular photostress test in diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol 1990;108:1556-1558.
31. Sandberg MA, Gaudio AR: Slow photostress recovery and disease severity in age-related macular degeneration. Retina 1995;15:407-412.
32. Falsini B, Porciatti V, Bolzani R, Marchionni A: Spatial-frequency-dependent changes in the human pattern electroretinogram after acute acetyl-L-carnitine administration. Graefes Arch Clin Exp Ophthalmol 1991;229:262-266.
33. Lowitt S, Malone M, Salem A, Kozak WM, Orfalian Z: Acetyl-L-carnitine corrects electroretinographic deficits in experimental diabetes. Diabetes 1993;42:1115-1118.
34. Olatunji-Bello II, Reiter RJ: Effect of acute acetyl-L-carnitine treatment on daytime melatonin synthesis in the rat. Afr J Med Med Sci 1997;26:175-177.
35. Alagoz G, Celiker U, Ilhan N, Yekeler H, Demir T, Celiker H: L-Carnitine in experimental retinal ischemia-reperfusion injury. Ophthalmologica 2002;216:144-150.
36. Rodriguez de Turco EB, Gordon WC, Peyman GA, Bazan NG: Preferential uptake and metabolism of decosahexaenoic acid in membrane phospholipids from rod and cone photoreceptor cells of human and monkey retinas. J Neurosci Res 1990;17:522-532.
37. Rodriguez de Turco EB, Deretic D, Bazan NG, Papermaster DS: Post-Golgi vesicles cotransport decosahexaenoyl-phospholipids and rhodopsin during frog photoreceptor membrane biogenesis. J Biol Chem 1997;272:10491-10497.
38. Weisinger HS, Vingrys AJ, Bui BV, Sinclair AJ: Effect of dietary n-3 fatty acid deficiency and repletion in the guinea pig retina. Invest Ophthalmol Vis Sci 1999;40:327-338.
39. Jeffrey BG, Mitchell DC, Gibson RA, Neuringen M: n-3 fatty acid deficiency alters recovery of the rod photoresponse in rhesus monkeys. Invest Ophthalmol Vis Sci 2002;43:2806-2814.
40. Reme CE, Malnoe A, Jung HH, Wei Q, Munz K: Effect of dietary fish oil on acute light-induced photoreceptor damage in the rat retina. Invest Ophthalmol Vis Sci 1994;35:78-90.
41. Uauy R, Hoffman DR: Essential fat requirements of preterm infants. Am J Clin Nutr 2000;71:245S-250S.
42. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG: A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000;42:174-181.
43. Hoffman DR, Birch EE, Birch DG, Uauy R, Castaneda YS, Lapus MG, Wheaton DH: Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr 2000;31:540-553.
44. Mares-Perlman JA, Brady WE, Klein R, Van den Langenberg GM, Klein BEK, Palta M: Dietary fat and age-related maculopathy. Arch Ophthalmol 1995;113:743-748.
45. Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon JM, Colditz GA, Hankinson SE: Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73:209-218.
46. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, Willett W: Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001;119:1191-1199.
47. Heuberger RA, Mares-Perlman JA, Klein R, Klein BE, Millen AE, Palta M: Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch Ophthalmol 2001;119:1833-1838.
48. Sanders TA, Haines AP, Wormald R, Wright LA, Obeid O: Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr 1993;57:428-433.
49. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gradoudas ES, Haller J, Miller DT, et al: Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration: Eye Disease Case-Control Study Group. JAMA 1994;272:1413-1420.
50. Smith W, Mitchell P, Webb K, Leeder SR: Dietary antioxidants and age-related maculopathy: The Blue Mountains Eye Study. Ophthalmology 1999;106:761-767.
51. Ikeda T, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Imamura Y, Koizumi K, Kinoshita S: Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 2001;132:191-195.
52. Belda Snachis JI, Quijada Gonzalez A, Munoz Ruiz G, Rodriguez-Galietero A, Romero Gomez FJ, Diaz-Llopis M: Are blood lipids a risk factor for age-related macular degeneration? Arch Soc Esp Oftalmol 2001;76:13-17.
53. Froyland L, Madsen L, Vaagenes H, Totland GK, Auwerx J, Kryvi H, Staels B, Berge RK: Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. J Lipid Res 1997;38:1851-1858.
54. Nelson GJ, Schmidt PC, Bartolini GL, Kelley DS, Kyle D: The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 1997;32:1137-1146.
55. Van den Langenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M: Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998;148:204-214.
56. Smith W, Mitchell P, Rochester C: Serum beta carotene, alpha tocopherol, and age-related maculopathy: The Blue Mountains Eye Study. Am J Ophthalmol 1997;124:838-840.
57. Age-Related Eye Disease Study Research Group: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No 8. Arch Ophthalmol 2001;119:1417-1436.
58. 10 play a role in opposing oxidative stress in patients with age-related macular degeneration? Ophthalmologica 2001;215:51-54.
59. 10 migliora la funzione visiva nella retinite pigmentosa. Clin Ocul Patol Ocul 1996;17:31-33.